Abacus Global Management Inc Dossier - Source-backed chat

Abacus Global Management Inc

ABXNYSE

SectorFinancials

IndustryInsurance - Life

Beta (adjusted)0.37

Intrinsic Value $9.37median of 6 methods · middle span $9-$44based on filings through 30 Jun 2026

Market Price $8.06Price as of 30 Sep 2026

UndervaluedIntrinsic value is 16% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $788.2M

Enterprise Value $1.1B

Shares Outstanding 101.2M diluted

Moat Rating Narrow

Next Earnings Date5 Nov 2026

Last ex-dividend2 Dec 2025

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Abacus Global Management, Inc. (NYSE: ABX) is successfully transitioning from a pure life settlement origination business into a diversified, high-margin alternative asset management platform. The company's proprietary longevity data and LifeARC AI platform provide a unique competitive advantage in pricing lifespan-linked financial products. The strategic minority investment and alliance with Manning & Napier ($18B AUM) significantly expands its distribution channels, paving the way for robust, recurring fee-based revenue streams.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets6 analysts · as of 18 Aug 2026

Low · most bearish analyst$12.00

Mean target$14.08

High · most bullish analyst$16.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

Regulatory changes in the life settlement market or a shift in macroeconomic conditions compress margins. Integration with Manning & Napier faces delays, and capital deployment for policy purchases slows down, keeping the company dependent on transactional origination revenue.

Base CaseCentral scenario

The company achieves its raised FY2026 adjusted net income guidance of $100M to $106M, driven by consistent longevity fund inflows, scaling of its ETF strategies, and successful monetization of its 10,000 monthly leads through the Manning & Napier alliance. Operating margins remain stable at ~55% EBITDA.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Unique, uncorrelated asset class (longevity-based assets) providing a strong hedge against traditional market volatility.
High-margin business model with Q1 2026 Adjusted EBITDA margin sustained at 55%.
Strategic alliance with Manning & Napier provides immediate access to an $18B AUM wealth platform and 3,400 clients.
Strong cash generation, with Q1 2026 operating cash flow swinging to positive $91.7M.

Key Investment Risks

Heavy reliance on the Life Solutions segment for near-term revenue, making the company vulnerable to origination volume fluctuations.
Regulatory and compliance risks associated with life insurance settlements and consumer privacy laws.
Execution risk in scaling the asset management and wealth advisory divisions.

Thesis Invalidation Triggers

Average realized gain on policy sales drops consistently below the 20% target.
Failure to achieve the lower bound of FY2026 adjusted net income guidance ($100M).
A material weakness is identified in internal controls over financial reporting as the company scales.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.